Be a part of 3^rd International Conference on Alzheimers Disease and Dementia

The 3rd International Conference on Alzheimer's Disease and Dementia, taking place on September 22-23, 2025, in London, UK, offers an opportunity to explore the latest advancements in Alzheimer's research and treatment. Here’s why you should attend:

• Explore Cutting-Edge Research – Gain insights into the latest discoveries in genetics, molecular biology, clinical trials, and innovative therapies.
• Discover Emerging Treatments – Learn about novel strategies to slow disease progression, manage symptoms, and enhance patient care.
• Apply Practical Knowledge – Whether you’re a healthcare provider or a researcher, access evidence-based solutions for real-world challenges.
• Engage with Global Experts – Connect with leading professionals, collaborate on research, and establish valuable partnerships.

• Traumatic Brain Injury (TBI) & Recovery
• Neurotransmitters: The Brain Chemical Messengers
• Neuroplasticity & Brain Adaptability
• Parkinson’s disease & The Brain
• Dementia & Cognitive Disorders
• Mental Health & Psychiatry
• ADHD & Executive Functioning
• Bipolar Disorder & Mood Regulation
• Cutting-Edge Brain Science & Future Treatments
• Brain Imaging Technologies
• The Role of AI in Neuroscience
• Psychedelics & Mental Health
• CRISPR & Brain Disorders
• The Future of Psychiatry
• Stroke & Brain Recovery
• The Gut-Brain Connection
• Hormones & The Brain
• Nutrition for a Healthy Brain
• Epilepsy: Seizures & The Nervous System

This conference is designed for:

• Neurologists, psychiatrists, and neuroscientists are studying Alzheimer’s, dementia, and related neurodegenerative disorders.
• Medical researchers and scientists are exploring the molecular and genetic foundations of dementia.
• Healthcare professionals and caregivers, including geriatricians, nurses, and social workers, are involved in dementia care.
• Pharmaceutical and biotech professionals are developing therapies and technologies for treatment and disease management.
• Policy makers, public health officials, and advocates are shaping healthcare policies and dementia-related initiatives.
• Students and academics researching neurodegenerative diseases and their societal impact.

Join us in London for a collaborative exchange of knowledge, innovative discussions, and meaningful networking opportunities in the field of Alzheimer's research and dementia care.

• Oral Presentations – Present your research to a global audience, gain valuable feedback, and engage in discussions with experts.
• Poster Sessions – Showcase your work through a poster presentation and connect with peers and industry professionals in an interactive setting.
• Networking Opportunities – Participate in social events designed to encourage collaboration, idea exchange, and professional growth.
• Exhibitions – Discover cutting-edge technologies, tools, and services transforming Alzheimer's and dementia care.
• Certification – Receive a certificate of participation, acknowledging your contribution to advancing research and innovation in the field.

The Alzheimer’s Disease 2025 Market is Segmented by Alzheimer’s Disease 2025 Disorder (Depression, Bipolar Disorder, Schizophrenia, Anxiety, Post-Traumatic Stress Disorder (PTSD), and Other Mental Disorders), Services (Inpatient Treatment Services, Residential Treatment Services, Outpatient Treatment Services, Emergency Alzheimer’s Disease 2025 Services, and Other Alzheimer’s Disease 2025 Services), Age Group (Paediatric, Adult, and Geriatric), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report offers the value (USD) for the above segments.

The Alzheimer’s Disease 2025 market is expected to register a CAGR of 3.5% over the forecast period.

• Globally, COVID-19 had a major impact on the Alzheimer’s Disease 2025 market due to a few mental illnesses that were observed during the lockdown. For instance, as per the research brief published by the World Health Organization (WHO) in March 2022, anxiety and sadness increased dramatically by 25% worldwide in the first year of the COVID-19 pandemic. The increasing prevalence of Alzheimer’s Disease 2025 problems, along with severe disruption of Alzheimer’s Disease 2025 services, has led to large gaps in care during the initial stage of the pandemic. However, the market attains growth through remote Alzheimer’s disease 2025care services provided by various healthcare facilities.
• The primary factors that drive the market growth are the increasing prevalence of mental disorders, along with the rising geriatric population and rising Alzheimer’s Disease 2025 awareness through campaigns. Mental illnesses include many different conditions that vary in degree of severity, ranging from mild to moderate to severe. According to the report published by WHO in June 2022, 1 in every 8 people in the world lives with a mental disorder that involves significant disturbances in thinking, emotional regulation, or behaviour. 
• Similarly, as per the report published by the Alzheimer’s Disease 2025 Foundation, in 2022-23, an average of 37.1% of women and 29.9% of men reported high levels of anxiety in the United Kingdom. This shows the high burden of mental disorders globally and regionally, which is expected to have a significant impact on the market.
• Furthermore, the new campaigns increase the awareness of Alzheimer’s Disease 2025 in public and seek Alzheimer’s Disease 2025 services which are likely to have a significant impact on the market growth. For instance, in May 2023, the National Alliance on Mental Illness (NAMI) launched More Than Enough, an empowering campaign for 2023 Alzheimer’s Disease 2025 Awareness Month. This campaign aims to address urgent needs and create a sense of belonging for people with ongoing Alzheimer’s Disease 2025 crises, which makes them have proper treatment using Alzheimer’s Disease 2025 services and likely propel the market growth over the study period.

However, rising costs of Alzheimer’s Disease 2025 services are expected to hinder market growth over the forecast period.